查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2023533

衝擊波療法市場分析及預測（至2035年）：類型、產品、服務、技術、應用、最終用戶、功能

Shockwave Therapy Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Functionality
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球衝擊波治療市場預計將從2025年的19億美元成長到2035年的41億美元，複合年成長率（CAGR）為7.8%。該市場穩步擴張的原因在於肌肉骨骼疾病數量的增加以及對非侵入性治療方法需求的成長。根據世界衛生組織全球健康觀察站的數據，全球有超過17億人患有肌肉骨骼疾病，為此治療方法的應用奠定了堅實的臨床基礎。預計到2025年，該市場規模將達到11億美元至13億美元，複合年成長率為中等個位數。整形外科領域仍然是該市場的主導領域，這主要得益於肌腱疾病、慢性疼痛和運動傷害的高發生率。醫院和專科診所的使用佔了該市場的大部分佔有率，這主要得益於衝擊波治療與物理治療的日益融合以及人們對非藥物門診治療方法的偏好不斷增強。

在整形外科和復健醫學領域，衝擊波療法市場正穩步擴張，這主要得益於人們對非侵入性疼痛管理和組織再生解決方案日益成長的需求。衝擊波療法能夠刺激細胞修復、改善血液循環並促進癒合，且無需手術干預，因此被廣泛用於治療足底筋膜炎、肌腱疾病、肩周炎鈣化和慢性下背痛等肌肉骨骼疾病。運動傷害發生率的上升、人口老化以及人們對門診和無藥物治療方法的日益青睞，進一步推動了市場滲透。此外，聚焦式和輻射式衝擊波技術的進步，以及物理治療基礎設施的不斷完善，也為已開發國家和新興國家醫療保健系統的市場持續成長提供了支持。

市場區隔
類型 徑向衝擊波療法、聚焦衝擊波療法、平面衝擊波療法
產品 攜帶式衝擊波裝置，固定式衝擊波裝置
服務 診所治療、居家治療
科技 電磁的、電解的、壓電的
適應 整形外科、泌尿系統、物理治療、美容醫學、獸醫學
最終用戶 醫院、專科診所、門診手術中心及居家醫療機構。
功能 疼痛管理、促進血液循環、細胞修復

整形外科領域在全球衝擊波治療市場中佔最大佔有率，並正在崛起成為主要且成長最快的應用領域。這一主導地位源自於慢性肌肉骨骼疾病的高發生率，以及衝擊波療法在臨床實踐中被廣泛接受，成為手術和長期藥物治療的有效替代方案。肌腱疾病和關節疼痛等患者數量的不斷增加，以及物理治療和復健中心對衝擊波系統的快速應用，都在推動市場需求。此外，設備精確度、治療效率和臨床效果的持續提升，也進一步加速了衝擊波療法的普及。隨著醫療保健支出的成長和運動醫學的拓展，整形外科仍然是該市場的主要收入來源。

區域概覽

北美憑藉其先進的醫療基礎設施、創新醫療技術的高普及率以及眾多領先設備製造商的強大實力，在衝擊波治療市場佔主導地位。該地區，尤其是美國，肌肉骨骼疾病和運動傷害的高發生率顯著推動了對非侵入性疼痛管理解決方案的需求。完善的保險報銷體係以及衝擊波治療與整形外科和物理治療實踐的緊密結合，進一步促進了市場滲透。此外，聚焦式和放射式衝擊波技術的早期應用，加上高昂的醫療費用支出以及患者對非藥物治療日益成長的偏好，鞏固了北美作為全球最大區域市場的地位。

由於醫療基礎設施的快速發展以及人們對非侵入性治療方法的認知不斷提高，亞太地區預計將成為衝擊波治療市場成長最快的地區。在中國、印度和日本等國家，肌肉骨骼疾病（尤其是老年族群）的盛行率不斷上升，推動了對復健治療的強勁需求。物理治療診所的擴張、醫療旅遊的發展以及對門診設施投資的增加，進一步促進了衝擊波治療的普及。此外，醫療保健支出的成長、先進醫療設備的普及以及本地製造能力的提升，都在加速市場成長。這些因素共同作用，使亞太地區成為全球成長最快的區域市場。

主要趨勢和促進因素

非侵入性、門診衝擊波療法正在取得進展。

隨著醫療保健系統優先考慮加快康復速度和減少手術依賴，衝擊波治療市場正經歷著向非侵入性、門診治療模式的強勁轉變。約60%至65%的整形外科和物理治療診所正擴大將衝擊波系統納入其常規肌肉骨骼護理方案，用於治療肌腱疾病和慢性疼痛等病症。推動這項轉變的另一個原因是患者越來越傾向於選擇恢復期短、無需藥物或微創的治療方法。攜帶式和聚焦式衝擊波設備在門診的日益普及提高了患者獲得治療的機會。此外，衝擊波治療與復健計畫和聯合治療的結合，也提高了其在全球醫療機構的臨床接受度。

肌肉骨骼疾病負擔日益加重，推動了臨床需求的成長。

全球肌肉骨骼疾病負擔日益加重，是衝擊波治療市場的主要成長要素。根據世界衛生組織估計，骨關節炎、足底筋膜炎和慢性下背痛等疾病影響全球超過17億人。已開發國家約有20-25%的成年人患有慢性肌肉骨骼疼痛，顯著增加了對長期、非侵入性治療方法的需求。人口老化、久坐的生活方式以及運動傷害的增加，進一步加劇了患者湧入醫院和專科診所的趨勢。這種不斷擴大的疾病負擔正在加速衝擊波治療作為一種有效替代手術和長期藥物鎮痛策略的療法的普及。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 徑向衝擊波療法
    • 聚焦衝擊波療法
    • 平面衝擊波療法
  • 市場規模及預測：依產品分類
    • 攜帶式衝擊波治療儀
    • 固定式衝擊波治療設備
  • 市場規模及預測：依服務分類
    • 住院治療
    • 居家治療
  • 市場規模及預測：依技術分類
    • 電磁
    • 電液式
    • 壓電
  • 市場規模及預測：依應用領域分類
    • 整形外科
    • 泌尿系統
    • 物理治療
    • 美容醫學
    • 獸醫學
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 專科診所
    • 門診手術中心
    • 居家照護環境
  • 市場規模及預測：依功能分類
    • 疼痛管理
    • 血流刺激
    • 細胞修復

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Zimmer Biomet
  • DJO Global（Enovis/Chattanooga）
  • BTL Industries
  • Storz Medical
  • EMS Electro Medical Systems（EMS DolorClast）
  • MTS Medical
  • Richard Wolf
  • Boston Scientific
  • Enraf-Nonius
  • Medispec
  • GymnaUniphy
  • TensCare
  • Venn Healthcare
  • Dornier MedTech
  • Lumenis
  • Siemens Healthineers
  • Olympus Corporation
  • Shockwave Medical
  • DirexGroup
  • Likamed GmbH

第9章 關於我們

簡介目錄
Product Code: GIS34557

The global Shockwave Therapy Market is projected to grow from $1.9 billion in 2025 to $4.1 billion by 2035, at a compound annual growth rate (CAGR) of 7.8%. The shockwave therapy market is expanding steadily due to rising cases of musculoskeletal disorders and increasing demand for non-invasive treatment options. According to WHO Global Health Observatory data, musculoskeletal conditions affect over 1.7 billion people worldwide, creating a strong clinical base for therapy adoption. The market is estimated at USD 1.1-1.3 billion in 2025 and is growing at a mid-single-digit CAGR. Orthopedics remains the dominant segment, driven by high incidence of tendon disorders, chronic pain, and sports injuries. Hospitals and specialty clinics account for the majority of usage, supported by physiotherapy integration and growing preference for drug-free, outpatient treatment approaches.

The shockwave therapy market is expanding steadily within orthopedics and rehabilitative medicine applications, driven by increasing demand for non-invasive pain management and tissue regeneration solutions. Shockwave therapy is widely used for treating musculoskeletal disorders such as plantar fasciitis, tendinopathies, calcific shoulder pain, and chronic back pain due to its ability to stimulate cellular repair, improve blood circulation, and accelerate healing without surgical intervention. Rising incidence of sports injuries, aging populations, and growing preference for outpatient and drug-free treatment options are further strengthening market adoption. Additionally, advancements in focused and radial shockwave technologies, along with expanding physiotherapy infrastructure, are supporting sustained market growth across developed and emerging healthcare systems.

Market Segmentation
TypeRadial Shockwave Therapy, Focused Shockwave Therapy, Planar Shockwave Therapy
ProductPortable Shockwave Devices, Fixed Shockwave Devices
ServicesIn-Clinic Treatment, Home-Based Therapy
TechnologyElectromagnetic, Electrohydraulic, Piezoelectric
ApplicationOrthopedics, Urology, Physiotherapy, Aesthetic Medicine, Veterinary
End UserHospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings
FunctionalityPain Management, Blood Flow Stimulation, Cellular Repair

The orthopedics segment is emerging as the dominant and highest-growing application category, accounting for the largest share of the global shockwave therapy market. This dominance is driven by the high prevalence of chronic musculoskeletal conditions and the widespread clinical acceptance of shockwave therapy as an effective alternative to surgery and long-term pharmacological treatment. Increasing patient inflow for conditions such as tendon disorders and joint pain, along with strong integration of shockwave systems in physiotherapy and rehabilitation centers, is reinforcing demand. Moreover, continuous improvements in device precision, treatment efficiency, and clinical outcomes are further accelerating adoption. Growing healthcare expenditure and expanding sports medicine practices continue to make orthopedics the key revenue-generating segment in the market.

Geographical Overview

North America dominates the shockwave therapy market due to its advanced healthcare infrastructure, high adoption of innovative medical technologies, and strong presence of leading device manufacturers. The region experiences a high prevalence of musculoskeletal disorders and sports-related injuries, particularly in the United States, which significantly drives demand for non-invasive pain management solutions. Well-established reimbursement systems and strong integration of shockwave therapy into orthopedic and physiotherapy practices further support market penetration. Additionally, early adoption of focused and radial shockwave technologies, along with high healthcare expenditure and increasing patient preference for drug-free treatments, reinforces North America's position as the largest regional market globally.

Asia-Pacific is expected to be the fastest growing region in the shockwave therapy market due to rapid improvements in healthcare infrastructure and rising awareness of non-invasive treatment options. Increasing prevalence of musculoskeletal disorders, especially among aging populations in countries such as China, India, and Japan, is driving strong demand for rehabilitation therapies. Expanding physiotherapy clinics, growing medical tourism, and increasing investments in outpatient care facilities are further supporting adoption. Additionally, rising healthcare expenditure, improving access to advanced medical devices, and the expansion of local manufacturing capabilities are accelerating market growth. These factors collectively position Asia-Pacific as the fastest growing regional market globally.

Key Trends and Drivers

Rising Shift Toward Non-Invasive and Outpatient Shockwave Therapy Adoption

The shockwave therapy market is witnessing a strong shift toward non-invasive, outpatient-based treatment models as healthcare systems prioritize faster recovery and reduced surgical dependency. Nearly 60-65% of orthopedic and physiotherapy clinics are increasingly integrating shockwave systems into routine musculoskeletal care protocols for conditions such as tendon disorders and chronic pain. This shift is further supported by rising patient preference for drug-free and minimally invasive therapies that offer shorter downtime. The growing adoption of portable and focused shockwave devices in ambulatory settings is expanding treatment accessibility. Additionally, integration with rehabilitation programs and combination therapies is strengthening clinical acceptance across global healthcare facilities.

Rising Burden of Musculoskeletal Disorders Driving Clinical Demand Expansion

The increasing global burden of musculoskeletal disorders is a key growth driver for the shockwave therapy market, with conditions such as osteoarthritis, plantar fasciitis, and chronic back pain affecting over 1.7 billion people globally according to WHO estimates. Around 20-25% of the adult population in developed economies experiences chronic musculoskeletal pain, significantly increasing demand for long-term, non-invasive treatment options. Aging populations, sedentary lifestyles, and rising sports-related injuries are further intensifying patient inflow across hospitals and specialty clinics. This expanding disease burden is accelerating adoption of shockwave therapy as an effective alternative to surgery and long-term pharmacological pain management strategies.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Radial Shockwave Therapy
    • 4.1.2 Focused Shockwave Therapy
    • 4.1.3 Planar Shockwave Therapy
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Portable Shockwave Devices
    • 4.2.2 Fixed Shockwave Devices
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 In-Clinic Treatment
    • 4.3.2 Home-Based Therapy
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Electromagnetic
    • 4.4.2 Electrohydraulic
    • 4.4.3 Piezoelectric
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Orthopedics
    • 4.5.2 Urology
    • 4.5.3 Physiotherapy
    • 4.5.4 Aesthetic Medicine
    • 4.5.5 Veterinary
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Specialty Clinics
    • 4.6.3 Ambulatory Surgical Centers
    • 4.6.4 Home Care Settings
  • 4.7 Market Size & Forecast by Functionality (2020-2035)
    • 4.7.1 Pain Management
    • 4.7.2 Blood Flow Stimulation
    • 4.7.3 Cellular Repair

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Functionality
      • 5.5.5.8 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Zimmer Biomet
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 DJO Global (Enovis / Chattanooga)
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 BTL Industries
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Storz Medical
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 EMS Electro Medical Systems (EMS DolorClast)
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 MTS Medical
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Richard Wolf
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Boston Scientific
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Enraf-Nonius
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Medispec
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 GymnaUniphy
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 TensCare
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Venn Healthcare
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Dornier MedTech
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Lumenis
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Siemens Healthineers
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Olympus Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Shockwave Medical
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 DirexGroup
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Likamed GmbH
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us